Group 1 - The core point of the news is that Fengbei Biotechnology's stock has experienced a decline of 2.54%, with a total market value of 7.937 billion yuan and a cumulative drop of 6.73% over three consecutive days [1] - Fengbei Biotechnology, established on July 25, 2014, focuses on the comprehensive utilization of waste oil resources, with 91.18% of its revenue coming from this segment, including 79.60% from bio-based materials and 11.58% from biofuels [1] - The company's stock price is currently at 55.31 yuan per share, with a trading volume of 189 million yuan and a turnover rate of 10.80% [1] Group 2 - E Fund's fund holds a small position in Fengbei Biotechnology, with 88 shares representing 0.0002% of the circulating shares, ranking as the fourth largest holding [2] - The fund has incurred a floating loss of approximately 126.72 yuan today and a total floating loss of 351.12 yuan during the three-day decline [2] - E Fund's fund has a total asset size of 5.93 billion yuan, with a year-to-date return of 15.3% and a cumulative return of 20.92% since inception [2]
丰倍生物股价连续3天下跌累计跌幅6.73%，易方达基金旗下1只基金持88股，浮亏损失351.12元